CLS (CLI) Given “Buy” Rating at Liberum Capital

CLS (LON:CLI)‘s stock had its “buy” rating reissued by Liberum Capital in a research report issued to clients and investors on Wednesday. They currently have a GBX 300 ($3.83) price objective on the stock. Liberum Capital’s price target points to a potential upside of 35.14% from the stock’s previous close.

Separately, Peel Hunt reissued a “buy” rating on shares of CLS in a research note on Friday, July 27th.

Shares of LON CLI opened at GBX 222 ($2.83) on Wednesday. CLS has a twelve month low of GBX 170.22 ($2.17) and a twelve month high of GBX 256.42 ($3.27).

About CLS

CLS Holdings plc, together with its subsidiaries, engages in the investment, management, and development of commercial properties in the United Kingdom, France, Germany, and Sweden. The company operates in two segments, Investment Property and Other Investments. It also invests in hotels, corporate bonds, shares, and other corporate investments.

Recommended Story: Why Dividend Stocks May Be Right for You

Receive News & Ratings for CLS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CLS and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply